Pasar al contenido principal

PAPEL DEL TEJIDO ADIPOSO EN EL DESARROLLO DE HETEROGENEIDAD TUMORAL Y RESISTENCIA TERAPEUTICA EN MELANOMA: NUEVOS MODELOS DE ESTUDIO PARA DESCIFRAR LOS MECANISMOS MOLECULARES

PID2021-127645OA-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD REY JUAN CARLOS

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Vitamin D induces SIRT1 activation through K610 deacetylation in colon cancer

  • García-Martínez, José Manuel
  • Chocarro-Calvo, Ana
  • Martínez-Useros, Javier
  • Fernandez-Aceñero, M. Jesús
  • Fiuza, M. Carmen
  • Cáceres-Rentero, José
  • Vieja, Antonio de la
  • Barbáchano, Antonio
  • Muñoz Terol, Alberto
  • Larriba, María Jesús
  • García-Jiménez, Custodia
Posttranslational modifications of epigenetic modifiers provide a flexible and timely mechanism for rapid adaptations to the dynamic environment of cancer cells. SIRT1 is an NAD+ -dependent epigenetic modifier whose activity is classically associated with healthy aging and longevity, but its function in cancer is not well understood. Here, we reveal that 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3 , calcitriol), the active metabolite of vitamin D (VD), promotes SIRT1 activation through auto-deacetylation in human colon carcinoma cells, and identify lysine 610 as an essential driver of SIRT1 activity. Remarkably, our data show that the post-translational control of SIRT1 activity mediates the antiproliferative action of 1,25(OH)2D3 . This effect is reproduced by the SIRT1 activator SRT1720, suggesting that SIRT1 activators may offer new therapeutic possibilities for colon cancer patients who are VD deficient or unresponsive. Moreover, this might be extrapolated to inflammation and other VD deficiency-associated and highly prevalent diseases in which SIRT1 plays a prominent role., Funding for this work was provided by the Agencia Estatal de Investigación (PID2019- 104867RB-I00 / AEI/10.13039/501100011033, RTI2018-099343-B-100 and PID2021-127645OAI00); Instituto de Salud Carlos III (CIBERONC, CB16/12/00273 and CB16/12/00326); Comunidad de Madrid (Ayudas Atracción de Talento 2017-T1/BMD-5334 and 2021-5A/BMD-20951; A385- DROPLET Young Reserchers R&D Project 2019 CAM-URJC; PRECICOLON-CM, P2022/BMD7212); Universidad Rey Juan Carlos (ADIPOMELM, Proyecto Puente de Investigación 2020)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

SIRT1 Mediates the Antagonism of Wnt/β-Catenin Pathway by Vitamin D in Colon Carcinoma Cells

  • García-Martínez, José Manuel
  • Chocarro-Calvo, Ana
  • Martínez-Useros, Javier
  • Regueira-Acebedo, Nerea
  • Fernandez-Aceñero, M. Jesús
  • Muñoz, Alberto
  • Larriba, María Jesús
  • García-Jiménez, Custodia
Cancer initiation and progression result from genetic and epigenetic alterations caused by interactions between environmental and endogenous factors leading to aberrant cell signalling. Colorectal cancers (CRC) are linked to abnormal activation of the Wnt/β-catenin pathway, whose key feature is the nuclear accumulation of acetylated β-catenin in colon epithelial cells. Nuclear β-catenin acts as a transcriptional co-activator, targeting genes involved in cell proliferation and invasion. 1α,25-Dihydroxyvitamin D3 (1,25(OH)2D3 or calcitriol), the active form of vitamin D, antagonizes Wnt/β-catenin over-activation by engaging its high affinity receptor, VDR. Here we unveil that 1,25(OH)2D3-bound VDR activates Silent Information Regulator of Transcription, sirtuin 1 (SIRT1), leading to β-catenin deacetylation and nuclear exclusion, downregulation of its pro-tumourigenic target genes and inhibition of human colon carcinoma cell proliferation. Notably, orthogonal SIRT1 activation mimics nuclear exclusion of β-catenin while SIRT1 inhibition blocks the effects of 1,25(OH)2D3. Thus, SIRT1 emerges as a crucial mediator in the protective action of vitamin D against CRC. The mutual negative feedback loop unveiled here between Wnt and SIRT1 represents an important surrogate target in CRC. Since nuclear localisation of β-catenin is a critical driver of CRC that requires its acetylation, we provide a mechanistic foundation for the epidemiological evidence linking vitamin D deficiency and increased CRC risk and mortality., Funding for this work was provided by the Agencia Estatal de Investigación MCIN/AEI/10.13039/501100011033 (PID2019-104867RB-I00); Agencia Estatal de Investigación MCIN/AEI/10.13039/501100011033 and FEDER Una manera de hacer Europa (PID2021-127645OA-I00 and PID2022-136729OB-I00); Comunidad de Madrid (PEJ-2021-AI/BMD-22973 and PEJ-2021-TL/BMD-21515; Ayudas Atracción de Talento 2017-T1/BMD-5334 and 2021-5A/BMD-20951; A385-DROPLET Young Researchers R&D Project 2019 CAM-URJC; PRECICOLON-CM, P2022/BMD-7212); Universidad Rey Juan Carlos (ADIPOMELM, Proyecto Puente de Investigación 2020); and Instituto de Salud Carlos III, Fondo Europeo de Desarrollo Regional (CIBER-ONC/CB16/12/00273)., Peer reviewed